SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithkline Consumer reports 18% jump in Q3 consolidated net

07 Feb 2012 Evaluate

GlaxoSmithkline Consumer Healthcare has reported results for third quarter ended December 31, 2011.

The company has posted a rise of 10.74% in its net profit of Rs 59.10 crore for the quarter ended December 31, 2011 as compared to Rs 53.37 crore for the same quarter in the previous year. Total income has increased by 20.30% from Rs 540.90 crore for Q3FY11 to Rs 650.70 crore in the quarter under review.

On the consolidated basis, the group has posted a jump of 18.48% in its net profit to Rs 355.21 crore for the quarter ended December 31, 2011 as compared to Rs 299.81 crore in the same quarter last year. Total income of the company improved by 17.61% to Rs 2,850.26 crore for the quarter compared to Rs 2,423.51 crore in the quarter, year ago.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 461.30
Nestle 1258.55
Britannia Inds 5589.50
LT Foods 419.20
Hatsun Agro Product 939.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×